Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurotec in Symptomatic Diabetic Neuropathy
IRCT138802201044N3Phase 3Completed
- Sponsor
- Pars Roos
- Start
- Oct 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Neurotec in diabetic neuropathy, sponsored by Pars Roos. Started Oct 2009; status: completed.
02
Drugs
Neurotec
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT138802201044N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138802201044N3.